ジェットインジェクターデバイスの世界市場:粉末及び液体、デポ

LINEで送る

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
• PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
• Comparison by type
• Powder and liquid – Market size and forecast 2018-2023
• Depot – Market size and forecast 2018-2023
• Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
• PART 11: MARKET TRENDS
• Technological advancements in jet injector devices
• Business strategies
• Increasing focus on the development of biologics
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Antares Pharma, Inc.
• Beijing Kushur Medical Technology Co. Ltd.
• Crossject
• Endo International Plc
• European Pharma Group BV
• INJEX Pharma GmbH
• Inovio Pharmaceuticals Inc.
• Medical International Technologies Inc.
• National Medical Products Inc.
• PharmaJet Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Product overview
Exhibit 02: Global medical devices market
Exhibit 03: Segments of global medical devices market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Type – Market share 2018-2023 (%)
Exhibit 19: Comparison by type
Exhibit 20: Powder and liquid – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Powder and liquid – Year-over-year growth 2019-2023 (%)
Exhibit 22: Depot – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Depot – Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by type
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2018-2023 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 29: Number of cases of infectious diseases in 2016 in the US
Exhibit 30: Rate of vaccination coverage among the population aged 19 to 35 months in 2016 in US
Exhibit 31: North America – Year-over-year growth 2019-2023 (%)
Exhibit 32: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Geriatric population aged 65 years and above (2016 & 2018) in Europe
Exhibit 34: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 35: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 37: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 38: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 39: Key leading countries
Exhibit 40: Market opportunity
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Antares Pharma Inc. – Vendor overview
Exhibit 48: Antares Pharma Inc. – Organizational developments
Exhibit 49: Antares Pharma Inc. – Geographic focus
Exhibit 50: Antares Pharma Inc. – Key offerings
Exhibit 51: Antares Pharma Inc. – Key customers
Exhibit 52: Beijing Kushur Medical Technology Co. Ltd. – Vendor overview
Exhibit 53: Beijing Kushur Medical Technology Co. Ltd. – Key offerings
Exhibit 54: Beijing Kushur Medical Technology Co. Ltd. – Key customers
Exhibit 55: Crossject – Vendor overview
Exhibit 56: Crossject – Organizational developments
Exhibit 57: Crossject – Key offerings
Exhibit 58: Crossject – Key customers
Exhibit 59: Endo International Plc – Vendor overview
Exhibit 60: Endo International Plc – Business segments
Exhibit 61: Endo International Plc – Organizational developments
Exhibit 62: Endo International Plc – Segment focus
Exhibit 63: Endo International Plc – Key offerings
Exhibit 64: Endo International Plc – Key customers
Exhibit 65: European Pharma Group BV – Vendor overview
Exhibit 66: European Pharma Group BV – Key offerings
Exhibit 67: European Pharma Group BV – Key customers
Exhibit 68: INJEX Pharma GmbH – Vendor overview
Exhibit 69: INJEX Pharma GmbH – Product segments
Exhibit 70: INJEX Pharma GmbH – Key offerings
Exhibit 71: INJEX Pharma GmbH – Key customers
Exhibit 72: Inovio Pharmaceuticals Inc. – Vendor overview
Exhibit 73: Inovio Pharmaceuticals Inc. – Organizational developments
Exhibit 74: Inovio Pharmaceuticals Inc. – Key offerings
Exhibit 75: Inovio Pharmaceuticals Inc. – Key customers
Exhibit 76: Medical International Technologies Inc. – Vendor overview
Exhibit 77: Medical International Technologies Inc. – Product segments
Exhibit 78: Medical International Technologies Inc. – Key offerings
Exhibit 79: Medical International Technologies Inc. – Key customers
Exhibit 80: National Medical Products Inc. – Vendor overview
Exhibit 81: National Medical Products Inc. – Key offerings
Exhibit 82: National Medical Products Inc. – Key customers
Exhibit 83: PharmaJet Inc. – Vendor overview
Exhibit 84: PharmaJet Inc. – Organizational developments
Exhibit 85: PharmaJet Inc. – Key offerings
Exhibit 86: PharmaJet Inc. – Key customers
Exhibit 87: Validation techniques employed for market sizing
Exhibit 88: Definition of market positioning of vendors




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様